+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents



Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents



Journal of Pharmacology and Experimental Therapeutics 301(1): 187-196



The present study examined the influence of dexefaroxan, a potent and selective alpha(2)-adrenoceptor antagonist, on cognitive performance in rodents. In young adult rats, dexefaroxan reversed the deficits induced by UK 14304 [5-bromo-N-(4,5-dihydro-1-H-imidazol-2-yl)-6-quinoxalinamine], scopolamine, and diazepam in a passive avoidance task. In this test, dexefaroxan also attenuated the spontaneous forgetting induced by a 15-week training-testing interval. Moreover, dexefaroxan, given immediately after training, increased the memory performance of rats trained with a weak electric footshock in the passive avoidance test, facilitated spatial memory processes in the Morris water maze task in rats, and increased the performance of mice in an object recognition test. Thus, dexefaroxan appears to have a promnesic effect in these tests by facilitating the processes of memory retention, rather than acquisition or other noncognitive influences. The facilitatory effects of dexefaroxan in young adult rats persisted even after a 21- to 25-day constant subcutaneous infusion by using osmotic minipumps, indicating that tolerance to the promnesic effect of the drug did not occur during this prolonged treatment interval. Furthermore, in the passive avoidance and Morris water maze tests, dexefaroxan ameliorated the age-related memory deficits of 24-month-old rats to a level that was comparable to that of young adult animals, and reversed the memory deficits induced by excitotoxin lesions of the nucleus basalis magnocellularis region. Together, these findings support a potential utility of dexefaroxan in the treatment of cognitive deficits occurring in Alzheimer's disease.

(PDF emailed within 1 workday: $29.90)

Accession: 010544164

Download citation: RISBibTeXText

PMID: 11907173


Related references

Effects of medetomidine, an alpha-2 adrenoceptor agonist, and atipamezole, an alpha-2 antagonist, on spatial memory performance in adult and aged rats. Behavioral and Neural Biology 58(2): 113-119, 1992

Protective effects of the alpha 2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat. Neuroscience 115(1): 41-53, 2002

Protective effect of the alpha2-adrenoceptor antagonist, dexefaroxan, against spatial memory deficit induced by cortical devascularization in the adult rat. Experimental Neurology 185(1): 198-200, 2003

Alpha 1-adrenoceptor antagonist decreases alpha 2-adrenoceptor antagonist-induced high voltage spindle suppression in adult and aged rats. European Journal of Pharmacology 235(2-3): 317-320, 1993

Dexefaroxan, an alpha2-adrenoceptor antagonist, protects against cortico-basalis cholinergic degeneration in the adult rat. Society for Neuroscience Abstracts 27(1): 1456, 2001

Anti-apoptotic effect of the alpha2-adrenoceptor antagonist dexefaroxan in the olfactory bulb of adult rat brain in vivo. Society for Neuroscience Abstracts 26(1-2): Abstract No -514 17, 2000

Regional selectivity of the alpha-2-adrenoceptor antagonist dexefaroxan increase acetylcholine release in the rat brain in vivo. Society for Neuroscience Abstracts 23(1-2): 2016, 1997

Effects of the alpha 2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death. Neuroscience 117(2): 281-291, 2003

The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. European Journal of Pharmacology 387(2): 141-150, 2000

The effects of ethanol in combination with the alpha 2-adrenoceptor agonist dexmedetomidine and the alpha 2-adrenoceptor antagonist atipamezole on brain monoamine metabolites and motor performance of mice. European Journal of Pharmacology 292(2): 191-199, 1995

The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatching to position task. Pharmacology, Biochemistry, and Behavior 39(4): 1015-1019, 1991

The role of alpha 1L-adrenoceptor in rat urinary bladder: comparison between young adult and aged rats. Life Sciences 65(24): 2553-2559, 2000

Effects of alpha 2 adrenoceptor agonist and antagonist on spatial memory in rats. Langer, S Z , A M Galzin And J Costentin (Ed ) Advances in The Biosciences, Vol 82 Presynaptic Receptors And Neuronal Transporters; Satellite Symposium to The Iuphar (International Union Of Pharmacology) Congress, Rouen, France, June 26-29, 1990 Xx+352p Pergamon Press: Oxford, England, Uk; Elmsford, New York, Usa Illus 79-80, 1991

Biological evaluation of the alpha2-adrenoceptor antagonist dexefaroxan and its analogs for the treatment of neurodegenerative diseases. Abstracts of Papers American Chemical Society 221(1-2): MEDI 73, 2001

Synthesis and structure-activity relationships of compounds related to the alpha2-adrenoceptor antagonist dexefaroxan. Abstracts of Papers American Chemical Society 221(1-2): MEDI 72, 2001